000227.KO Yuyu Pharma Inc

Healthcare Pharmaceuticals Korea Stock Exchange
6,724 KRW
Close of Nov 4, 2026
5,810 12,267
Market cap
KRW 39.4B
P/E
-
P/B
-
ROE
10.6%
Dividend yield
4.90%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 000227.KO undervalued?

Graham number

The Graham number of Yuyu Pharma Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Yuyu Pharma Inc fundamental analysis

No fundamental analysis for Yuyu Pharma Inc yet.

Yuyu Pharma Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Yuyu Pharma Inc

Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.

Full company profile